 |
 |
 |
 |
|
|
Genomics in Cancer There is a tremendous need for new ways to manage and treat cancer, an extremely complex disease family that accounts for one out of every four deaths in the US. An individual cancer contains many different alterations. As a result, patients may be more or less likely to develop advanced disease or to respond to certain therapies. Because we have only limited insight into these differences at initial diagnosis, choosing a treatment tailored to the individual patient is extremely difficult. This is where genomics, the study of complex sets of genes, their expression, and their functions, comes in. New genomic services are being developed to provide clinically validated, individualized tumor profiles which may greatly improve the quality of treatment decisions for patients with cancer. Genomic Health’s initial diagnostic test, Oncotype DX®, is already providing significant new insights for breast cancer treatment. Oncotype DX has been clinically validated to predict the likelihood of breast cancer recurrence and also assesses the benefit from chemotherapy.1 Click here to learn more about Oncotype DX
|
 |
|
|
|
|
| Copyright © 2008 Genomic Health, Inc. All rights reserved. | | Contact Us | Site Map | Privacy | Terms and Conditions | |